SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
2019 · Clinical & Translational Oncology · 69 citations
https://doi.org/10.1007/s12094-019-02262-0
S
Santiago González-Santiago
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
941
Citations
13
h-index
17
i10-index
Santiago González-Santiago is an academic researcher from Hospital San Pedro de Alcántara. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 13, co-authored 47 publications.
ORCID: 0000-0002-4787-0236Papers by this author
worksSEOM clinical guidelines on cardiovascular toxicity (2018)
2019 · Clinical & Translational Oncology · 33 citations
https://doi.org/10.1007/s12094-018-02017-3
Prevalence of Homologous Recombination Deficiency Among Patients With Germline <i>RAD51C/D</i> Breast or Ovarian Cancer
2024 · JAMA Network Open · 18 citations
https://doi.org/10.1001/jamanetworkopen.2024.7811
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
2022 · The Breast · 6 citations
https://doi.org/10.1016/j.breast.2022.09.006
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.
2015 · PubMed · 3 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat